ATLA on special liability protections for vaccine producers

ATLA on special liability protections for vaccine producers

The Association of Trial Lawyers of America (ATLA) has called for Congress to reject Merck’s demand for special liability protections for its vaccines. ATLA pointed to the New England Journal of Medicine which has recently revealed that the authors of a Merck-funded study of Vioxx altered the results to conceal that three additional patients in the study suffered heart attacks while using the drug.